AHA GUIDELINES Bundle (free trial)

Blood Cholesterol

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512420

Contents of this Issue

Navigation

Page 14 of 31

15 4.4.2. Primary Prevention Adults 40 to 75 Years of Age With LDL-C Levels 70 to 189 mg/dL (1.7 to 4.8 mmol/L) COR LOE Recommendations IIb B-R 8. In intermediate-risk adults who would benefit from more aggressive LDL-C lowering and in whom high-intensity statins are advisable but not acceptable or tolerated, it may be reasonable to add a nonstatin drug (ezetimibe or bile acid sequestrant) to a moderate-intensity statin. IIb B-R 9. In patients at borderline risk, in risk discussion, the presence of risk-enhancing factors may justify initiation of moderate- intensity statin therapy. a Definition of clinical ASCVD includes acute coronary syndrome (ACS), those with history of myocardial infarction (MI), stable or unstable angina or coronary or other arterial revascularization, stroke, transient ischemic attack (TIA), or peripheral artery disease (PAD) including aortic aneurysm, all of atherosclerotic origin. Table 5. Checklist for Clinician–Patient Shared Decision- Making for Initiating Therapy Checklist Item Recommendation Possible Management Strategy ASCVD risk assessment • Assign to statin treatment group; use ASCVD Risk Estimator Plus. a ▶ In lower-risk primary-prevention adults 40-75 y of age with LDL-C ≥70 mg/dL (≥1.8 mmol/L). ▶ Not needed in secondary prevention, in those with LDL-C ≥190 mg/dL (≥4.9 mmol/L), or in those 40-75 y of age with diabetes mellitus. • Assess other patient characteristics that influence risk. See Risk-Enhancing Factors (see Table 4) • Assess CAC if risk decision is uncertain and additional information is needed to clarify ASCVD risk. ▶ Use decision tools to explain risk (e.g., ASCVD Risk Estimator Plus,* Mayo Clinic Statin Choice Decision Aid). Lifestyle modifications • Review lifestyle habits (e.g., diet, physical activity, weight or body mass index, and tobacco use). • Endorse a healthy lifestyle and provide relevant advice, materials, or referrals. (e.g., CardioSmart, AHA Life's Simple 7, NLA Patient Tear Sheets, PCNA Clinicians' Lifestyle Modification Toolbox, cardiac rehabilitation, dietitian, smoking cessation program).

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Blood Cholesterol